The Med AI team bridges information from multimodal imaging and fluid biomarkers to model neurodegenerative disease onset and progression and to help fine-tune important clinical questions.
Med AI comprises a multidisciplinary, internationally diverse group of researchers, statisticians, programmers, and multimodal imaging experts. We have a rich history of collaborative projects with clinicians (clinical trial design and testing), private companies (pharma, software), and the Veteran’s Administration (Alzheimer’s Disease Neuroimaging Initiative, Traumatic Brain Injury, and Major Depression) to highlight a few. We welcome potential new team members and collaborations; please visit prospective partners pages to learn more.
STEM Learning Environment
The lab culture intentionally focuses on creating a STEM environment where team members flourish. We welcome and support the following key audiences and fields of study:
- Women in STEM and early career women in STEM
- Patients and clinicians involved in clinical trials
- Alzheimer’s research
- Biomedical imaging
- Brain imaging
- Artificial intelligence
- Innovation with AI and/or imaging
